No Data
Zhejiang Shouxiangu Pharmaceutical (603896.SH): Its main business does not involve secondary dimension cultural and creative products, games, and entertainment industry.
Gelonghui November 28th, zhejiang shouxiangu pharmaceutical (603896.SH) stated on the investor interaction platform that the company has its own cartoon fairy image commodities, but the company's main business does not involve secondary-dimensional cultural and creative products, games, and entertainment industry.
Zhejiang Shouxiangu Pharmaceutical (603896.SH): Intends to change some of the raise investment projects and postpone.
Shouxiangu (603896.SH) announced on November 27 that it plans to redirect some of the originally allocated funds to the "Shouxiangu Health Industry Park Health Food Phase II Construction Project (Production Line Construction)" to the "Smart Park Upgrade Project", with the total amount of redirected funds being 80.532 million yuan, accounting for 20.23% of the total amount of funds raised for the "Shou 22 Convertible Bonds". At the same time, the funds have generated cash management income and interest of 5.5861 million yuan, with the specific amount subject to the balance of the bank account on the day of fund transfer. Shouxiangu Health Industry Park Smart Park Upgrade Construction Project
Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Will Be Hoping To Turn Its Returns On Capital Around
Shouxiangu Pharmaceutical's Unit Gets Registration Certificate for Food Supplement; Shares Up 4%
Zhejiang Shouxiangu Pharmaceutical (603896.SH): Wholly-owned subsidiary completes filing of domestic health food.
Galaxy 6th November | Zhejiang Shouxiangu Pharmaceutical (603896.SH) announced that its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd.'s "Shouxiangu Mountain Brand Cracked Reishi Spore Powder" product has completed the domestic health food record-filing work and obtained the domestic health food record-filing certificate issued by Zhejiang Provincial Market Supervision Administration. The successful record-filing of the above product will not have a significant impact on the company's recent production and operation, but it is beneficial to further supplement and improve the company's product categories, enrich the company's product line, enhance the company's competitiveness in the health food field, in line with the company's strategic planning for expanding the healthy industry, laying a foundation for the enterprise's sustainable development.
Shou Sen Valley: Shousen Valley Third Quarter Report 2024
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (SHSE:603896) Prospects Need A Boost To Lift Shares
